Evidence map›Paper›PMID 27555800›Full record

ReviewHepatic medicine : evidence and research2016

Idiopathic noncirrhotic portal hypertension: current perspectives.

Oliviero Riggio, Stefania Gioia, Ilaria Pentassuglio, Valeria Nicoletti, Michele Valente, Giulia d'Amati

Open access · goldAbstract readReview
In one paragraph

Review in Hepatic medicine : evidence and research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. AiLIVER · 2022
    Review
  8. Article
  9. Article
  10. [Progress in the diagnosis and treatment of idiopathic non-cirrhotic portal hypertension].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021
    Article
  11. Review
  12. Undiagnosed liver diseases.Translational gastroenterology and hepatology · 2021
    Review
  13. Review
  14. [Analysis of influencing factors on hepatic encephalopathy in patients with non-cirrhotic portal hypertension].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2019
    Article
  15. Article
  16. Article
  17. Pathology of idiopathic non-cirrhotic portal hypertension.Virchows Archiv : an international journal of pathology · 2018
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Oliviero RiggioDepartment of Clinical Medicine, Center for the Diagnosis and Treatment of Portal Hypertension.
Stefania GioiaDepartment of Clinical Medicine, Center for the Diagnosis and Treatment of Portal Hypertension.
Ilaria PentassuglioDepartment of Clinical Medicine, Center for the Diagnosis and Treatment of Portal Hypertension.
Valeria NicolettiDepartment of Clinical Medicine, Center for the Diagnosis and Treatment of Portal Hypertension.
Michele ValenteDepartment of Radiological, Oncological, and Pathological Sciences, Sapienza University of Rome, Rome, Italy.
Giulia d'AmatiDepartment of Radiological, Oncological, and Pathological Sciences, Sapienza University of Rome, Rome, Italy.
Hypertension Institute · USSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The term idiopathic noncirrhotic portal hypertension (INCPH) has been recently proposed to replace terms, such as hepatoportal sclerosis, idiopathic portal hypertension, incomplete septal cirrhosis, and nodular regenerative hyperplasia, used to describe patients with a hepatic presinusoidal cause of portal hypertension of unknown etiology, characterized by features of portal hypertension (esophageal varices, nonmalignant ascites, porto-venous collaterals), splenomegaly, patent portal, and hepatic veins and no clinical and histological signs of cirrhosis. Physicians should learn to look for this condition in a number of clinical settings, including cryptogenic cirrhosis, a disease known to be associated with INCPH, drug administration, and even chronic alterations in liver function tests. Once INCPH is clinically suspected, liver histology becomes mandatory for the correct diagnosis. However, pathologists should be familiar with the histological features of INCPH, especially in cases in which histology is not only requested to exclude liver cirrhosis.

Indexed as

esophageal varicesidiopathic portal hypertensionobliterative portal venopathysplenomegaly

Identifiers

PMID27555800
PMCPMC4968980
OpenAlexW2482829433

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.